comparemela.com

Page 20 - Lxrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Xerox Target of Unusually Large Options Trading (NYSE:XRX)

Xerox Holdings Co. (NYSE:XRX – Get Rating) was the target of some unusual options trading activity on Wednesday. Stock traders bought 1,689 put options on the stock. This represents an increase of approximately 1,369% compared to the typical volume of 115 put options. Xerox Stock Up 0.3 % Shares of NYSE XRX opened at $14.62 […]

Community Bank & Trust Waco Texas Reduces Position in Deere & Company (NYSE:DE)

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 4,930,000 shares, an increase of 17.4% from the April 15th total of 4,200,000 shares. Based on an average daily volume of 607,900 shares, the days-to-cover ratio is […]

Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX) Sees Large Growth in Short Interest

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) saw a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 4,930,000 shares, a growth of 17.4% from the April 15th total of 4,200,000 shares. Based on an average trading volume of 607,900 shares, the short-interest ratio is […]

Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 12-Month High at $3 76

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating)’s stock price reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $3.76 and last traded at $3.64, with a volume of 2556757 shares. The stock had previously closed at $3.08. Analyst Upgrades and Downgrades LXRX has been the subject of […]

The Manufacturers Life Insurance Company Increases Stake in Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX)

The Manufacturers Life Insurance Company lifted its stake in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) by 126.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 35,943 shares of the biopharmaceutical company’s stock after acquiring an additional 20,065 shares […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.